Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002818
Status:
COMPLETED
Last Update Posted:
2015-12-14
First Post:
2000-08-03
Brief Title:
High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| DrugAgent Toxicity by TissueOrgan |
| Leukemia |
| Lymphoma |
| Multiple Myeloma and Plasma Cell Neoplasm |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| recurrent adult Hodgkin lymphoma | View |
| refractory multiple myeloma | View |
| recurrent adult acute myeloid leukemia | View |
| recurrent adult acute lymphoblastic leukemia | View |
| relapsing chronic myelogenous leukemia | View |
| blastic phase chronic myelogenous leukemia | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent adult Burkitt lymphoma | View |
| drugagent toxicity by tissueorgan | View |
| recurrent mantle cell lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |